Center for Scientific Review; Notice of Closed Meetings, 7438-7439 [2013-02153]
Download as PDF
<![CDATA[
7438
Federal Register / Vol. 78, No. 22 / Friday, February 1, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average time
per response
(in hours)
Annual burden
hours
Type of respondents
Instrument
Clinical Trials .....................................
Initial Registration .............................
Amendment ......................................
Accrual Updates ...............................
5,500
5,500
5,500
1
4
4
2
1
15/60
11,000
22,000
5,500
Total ...........................................
...........................................................
16,500
........................
........................
38,500
Dated: January 25, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Cancer Institute (NCI), National Institutes of
Health (NIH).
[FR Doc. 2013–02123 Filed 1–31–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Development of Human
Monoclonal Antibodies Against DR4
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an exclusive
evaluation option license to practice the
inventions embodied in PCT Patent
Application No. PCT/US2011/040750
and foreign equivalents thereof entitled
‘‘Agonistic Human Monoclonal
Antibodies Against DR4’’ (HHS Ref. No.
E–158–2010/0) to Customized
Biosciences, Inc., which is located in
Pasadena, CA. The patent rights in these
inventions have been assigned to the
United States of America.
The prospective start-up exclusive
commercial license territory may be
worldwide and the field of use may be
limited to ‘‘use of the Licensed Patent
Rights to develop therapeutic agents for
the treatment of lymphomas, leukemias,
hepatocellular cancer, colorectal cancer,
ovarian cancer, lung cancer, rheumatoid
arthritis, systemic lupus erythematosus,
multiple sclerosis, amyotrophic lateral
sclerosis, and Alzheimer’s disease’’.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
February 19, 2013 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
srobinson on DSK4SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:26 Jan 31, 2013
Jkt 229001
and other materials relating to the
contemplated exclusive evaluation
option license should be directed to:
Whitney A. Hastings, Ph.D., Licensing
and Patenting Manager, Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, MD 20852–3804;
Telephone: (301) 451–7337; Facsimile:
(301) 402–0220; Email:
hastingw@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The tumor
necrosis factor (TNF)-related apoptosisinducing ligand (TRAIL) and its
functional receptors, DR4 and DR5, have
been recognized as promising targets for
cancer treatment. Therapeutics targeting
TRAIL and its receptors are not only
effective in killing many types of tumors
but they also synergize with traditional
therapies, and show efficacy against
tumors that are otherwise resistant to
conventional treatments.
The above identified patent
application relates to the development
of two human monoclonal antibodies
(mAbs) that bind to death receptor 4
(‘‘DR4’’). The two mAbs were selected
from a human phage displayed Fab
library by panning against a
recombinant DR4 extracellular domain.
Therefore the two mAbs are fully
human. These antibodies could have
considerable potential as cancer
therapeutics alone or in combination
with other drugs. Further, these
antibodies could be used as a research
tool for the study of DR4.
The prospective start-up exclusive
commercial license is being considered
under the small business initiative
launched on 1 October 2011, and will
comply with the terms and conditions
of 35 U.S.C. 209 and 37 CFR 404.7. The
prospective start-up exclusive
commercial license, may be granted
unless the NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7 within
fifteen (15) days from the date of this
published notice.
Complete applications for a license in
the field of use filed in response to this
notice will be treated as objections to
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
the grant of the contemplated start-up
exclusive commercial license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: January 24, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–02152 Filed 1–31–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
Studies in Neonatal Resuscitation.
Date: February 27–28, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, gary.hunnicutt@nih.gov.
E:\FR\FM\01FEN1.SGM
01FEN1
srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 22 / Friday, February 1, 2013 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Dermatology, Rheumatology and
Inflammation.
Date: February 27, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–11–
100: Alzheimer’s Disease Pilot Clinical
Trials.
Date: February 27, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Societal and Ethical Issues in
Research.
Date: February 27, 2013.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, 301–594–
6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Par Panel:
Biobehavioral pathways of physical activity
and weight control on Cancer prognosis and
survival.
Date: February 27, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Healthcare
Delivery and Methodologies Academic
Research Enhancement Review.
Date: February 27, 2013.
Time: 12:00 p.m. to 4:00 p.m.
VerDate Mar<15>2010
17:26 Jan 31, 2013
Jkt 229001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Melinda Jenkins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
MSC 7770, Bethesda, MD 20892, 301–437–
7872, jenkinsml2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: February 28–March 1, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Hotel, 923 16th & K
Streets NW., Washington, DC 20006.
Contact Person: Mary Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, 301–451–
0996, marygs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PA12–006:
Academic Research Enhancement Award.
Date: February 28, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Riverwalk, 420 W
Market Street, San Antonio, TX 78205.
Contact Person: Rebecca Henry, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, 301–435–
1717, henryrr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Drug Discovery for Aging,
Neuropsychiatric and Neurologic, Disorders.
Date: February 28–March 1, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Chevy Chase
Pavilion, 4300 Military Rd. NW.,
Washington, DC 20015.
Contact Person: Yuan Luo, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5207 MSC 7846, Bethesda, MD
20892–7846, 301–827–7915.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Genes, Genomes, and Genetics.
Date: February 28, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Ross D Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6172,
MSC 7892, Bethesda, MD 20892, 301–435–
2786, ross.shonat@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Review of
Neuroscience AREA Grant Applications.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
7439
Date: February 28–March 1, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Alexandria, 480 King
Street, Alexandria, VA 22314.
Contact Person: Carole L Jelsema, Ph.D.,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7850, Bethesda, MD 20892, (301) 435–
1248, jelsemac@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group,
Social Sciences and Population Studies B
Study Section.
Date: February 28–March 1, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Valerie Durrant, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 827–
6390, durrantv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Epidemiology and Genetics of
Cancer.
Date: February 28, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Julia Krushkal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, 301–435–
1782, krushkalj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 25, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–02153 Filed 1–31–13; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Proposed Alterations to Pawtucket
Dam on the Merrimack River in Lowell,
MA; Public Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice of public meeting.
AGENCY:
Overview Information: Public meeting
to inform the drafting of formal
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 78, Number 22 (Friday, February 1, 2013)]
[Notices]
[Pages 7438-7439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02153]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA Panel: Studies in Neonatal Resuscitation.
Date: February 27-28, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD
20892, 301-435-0229, gary.hunnicutt@nih.gov.
[[Page 7439]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Dermatology, Rheumatology and Inflammation.
Date: February 27, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Aruna K Behera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD
20892, 301-435-6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-11-100: Alzheimer's Disease Pilot Clinical Trials.
Date: February 27, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark Lindner, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301-435-
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Societal and Ethical Issues in Research.
Date: February 27, 2013.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lisa Steele, Ph.D., Scientific Review Officer,
PSE IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD
20892, 301-594-6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Par Panel: Biobehavioral pathways of physical activity and
weight control on Cancer prognosis and survival.
Date: February 27, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-408-9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Healthcare Delivery and Methodologies Academic Research
Enhancement Review.
Date: February 27, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Melinda Jenkins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156, MSC 7770, Bethesda, MD
20892, 301-437-7872, jenkinsml2@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: February 28-March 1, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The St. Regis Hotel, 923 16th & K Streets NW.,
Washington, DC 20006.
Contact Person: Mary Schueler, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD 20892, 301-451-
0996, marygs@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PA12-006: Academic Research Enhancement Award.
Date: February 28, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westin Riverwalk, 420 W Market Street, San Antonio,
TX 78205.
Contact Person: Rebecca Henry, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, 301-435-
1717, henryrr@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Drug Discovery for Aging, Neuropsychiatric
and Neurologic, Disorders.
Date: February 28-March 1, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Chevy Chase Pavilion, 4300 Military Rd.
NW., Washington, DC 20015.
Contact Person: Yuan Luo, Scientific Review Officer, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5207 MSC 7846, Bethesda, MD 20892-7846, 301-827-7915.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Fellowships: Genes, Genomes, and Genetics.
Date: February 28, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Ross D Shonat, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6172, MSC 7892, Bethesda, MD 20892, 301-435-
2786, ross.shonat@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Review of Neuroscience AREA Grant Applications.
Date: February 28-March 1, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA
22314.
Contact Person: Carole L Jelsema, Ph.D., Chief and Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176, MSC 7850, Bethesda, MD
20892, (301) 435-1248, jelsemac@csr.nih.gov.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group, Social Sciences and Population Studies B
Study Section.
Date: February 28-March 1, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Valerie Durrant, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, (301) 827-6390, durrantv@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflicts: Epidemiology and Genetics of Cancer.
Date: February 28, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Julia Krushkal, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, 301-435-1782, krushkalj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 25, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-02153 Filed 1-31-13; 8:45 am]
BILLING CODE 4140-01-P
